Daily Newsletter

24 November 2023

Daily Newsletter

24 November 2023

Western University receives 15.2 Tesla MRI system

The system will allow trainees the opportunity of hands-on experience with advanced MRI technology.

Archana Rani November 24 2023

Western University in Canada has announced that its Schulich School of Medicine & Dentistry received what it claims to be the country’s first 15.2 Tesla magnetic resonance imaging (MRI) system.

The $6m Bruker preclinical scanner, which is intended for the Centre for Functional and Metabolic Mapping (CFMM), is expected to help researchers at the university study the brain with unprecedented resolution.

The new MRI system has been designed to support research on neurological disorders, including neuroimmunology research and a multicentre project focused on drug development for neurological conditions.

CFMM scientific director and professor Menon said: “This is one of the most powerful MRI systems in the world. The unprecedented spatial resolution and unique image contrast will help advance our understanding of neurological processes and assess new treatments in mouse models of disease.”

Scheduled to be ready for use by mid-2024, the preclinical system is planned to be housed in a biocontainment level two facility at the CFMM.

The system will offer trainees opportunities to gain hands-on experience with advanced technology and imaging techniques.

Using a high-powered magnetic field, MRI systems capture accurate and detailed images.

Menon added: “With the 15.2T MRI system, Western will be well-positioned to attract top-tier researchers and collaborators and expand its leadership in imaging and neuroscience research.”

In addition to the new advanced MRI platform, the CFMM houses Siemens 3T and 7T human MRI scanners and a Bruker 9.4T preclinical scanner.

Can Generative AI transform the medical devices industry?

The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation, which has improved efficiencies and enhanced patient outcomes. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns.

Newsletters by sectors


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.